Wednesday - April 29, 2026

Heparan Sulfate (HS) Oligosaccharides Effect in Liver Ischemia Reperfusion Injury

2026-03-10

ALEXANDRIA, Virginia, March 10 -- THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, Chapel Hill, North Carolina has been assigned a patent (No. US 12569512 B2, initially filed May 13, 2022) developed by four inventors Katelyn Arnold, Chapel Hill, North Carolina; Jian Liu, Chapel Hill, North Carolina; Rafal Pawlinski, Chapel Hill, North Carolina; and Brian Cooley, Chapel Hill, North Carolina, for "Heparan sulfate (HS) oligosaccharides effect in liver ischemia reperfusion injury." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Heparan Sulfate (HS) Oligosaccharides Effect in Liver Ischemia Reperfusion Injury

Information Request Form

Copyright Targeted News Service 2026